According to a Phase 3 noninferiority trial, 5% diquafosol eye drops demonstrate comparable efficacy and tolerability to 3% diquafosol for dry eye disease with a reduced dosing schedule. The double-blind,...

Topical azithromycin ophthalmic solution (Azyter, 15 mg/g) significantly improved disease symptoms and signs as second-line treatment for mixed dry eye disease (DED), according to a study. The prospective controlled pilot...

Adding a full-spectrum lamp to artificial tears improved subjective dry eye symptoms more in the short term in patients with visual display terminal (VDT)-related dry eye, but did not result... ...

The classification of dry eye disease (DED) risk factors has evolved substantially from the Tear Film and Ocular Surface Society (TFOS) International Dry Eye Workshop (DEWS) II report in 2017...